MVDP is a consortium of DBT, ICGEB, Malaria Vaccine Initiative (MVI), PATH, EMVI and WHO-TDR. MVDP was established as an independent society in July 2010. It takes vaccine projects up to proof of concept and efficacy studies (Phase II) and turns them over to companies for Phase III trial and commercialisation. Overall objective of the program is to promote the development of vaccines against P. falciparum and P. vivax malaria by leveraging the basic scientific work done by ICGEB and other scientific groups.
VIDRC was set in early 2009 as one of the niche centers of the newly established Translational Health Science and Technology Institute (THSTI). The aim of VIDRC is to study infectious diseases and pathogens with a view to develop effective vaccines and therapeutics.
CDSA is an extramural unit of THSTI and has been established as a not-for-profit society to provide cost affective, high quality preclinical and clinical product development support services to meet the country’s growing healthcare needs. It will tend enterprises; particularly SMEs involved in new technology innovation and facilitate translation of scientific know-how into viable products.
Established at CMC Vellore and KEM, Pune for vaccine research and development.